These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7543845)

  • 1. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
    Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
    Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers.
    Lobo DN; Stanga Z; Aloysius MM; Wicks C; Nunes QM; Ingram KL; Risch L; Allison SP
    Crit Care Med; 2010 Feb; 38(2):464-70. PubMed ID: 19789444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
    Halmágyi M
    Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
    Hausdörfer J; Hagemann H; Heine J
    Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydroxyethyl starch as plasma substitute: experiments in isovolamic haemodilution (author's transl)].
    Jesch F; Klövekorn WP; Sunder-Plassmann L; Seifert J; Messmer K
    Anaesthesist; 1975 May; 24(5):202-9. PubMed ID: 56900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial.
    Kasper SM; Dahlmann H; Mellinghoff H; Ellering J; Baumann M; Buzello W
    Vox Sang; 1998; 75(1):26-31. PubMed ID: 9745150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers.
    James MF; Latoo MY; Mythen MG; Mutch M; Michaelis C; Roche AM; Burdett E
    Anaesthesia; 2004 Aug; 59(8):738-42. PubMed ID: 15270962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers].
    Jung F; Koscielny J; Mrowietz C; Förster H; Schimetta W; Kiesewetter H; Wenzel E
    Arzneimittelforschung; 1993 Feb; 43(2):99-105. PubMed ID: 7681289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
    Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
    Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
    Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
    Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
    Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma volume expansion by medium molecular weight hydroxyethyl starch in neonates: a pilot study.
    Liet JM; Bellouin AS; Boscher C; Lejus C; Rozé JC
    Pediatr Crit Care Med; 2003 Jul; 4(3):305-7. PubMed ID: 12831411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.